Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

º¹¸· ¾ÏÁ¾ÁõÀ¸·Î ÁøÇàÇÑ ÀÚ°¡¸é¿ª¼º ÃéÀå¿° 1¿¹ Metachronous Development of Peritoneal Carcinomatosis in a Patient with Autoimmune Pancreatitis

´ëÇѼÒÈ­±âÇÐȸÁö 2020³â 75±Ç 6È£ p.356 ~ 361
À̱Կø, ÀåÀçÇõ, ±èÁø¾Æ, ±èÅÂÈ£, ±èâȯ, ±èÀ籤, ÇѼ®¿ø,
¼Ò¼Ó »ó¼¼Á¤º¸
À̱Կø ( Lee Kyu-Won ) 
Catholic University College of Medicine Department of Internal Medicine

ÀåÀçÇõ ( Chang Jae-Hyuck ) 
Catholic University College of Medicine Department of Internal Medicine
±èÁø¾Æ ( Kim Jean-A ) 
Catholic University College of Medicine Department of Pathology
±èÅÂÈ£ ( Kim Tae-Ho ) 
Catholic University College of Medicine Department of Internal Medicine
±èâȯ ( Kim Chang-Whan ) 
Catholic University College of Medicine Department of Internal Medicine
±èÀ籤 ( Kim Jae-Kwang ) 
Catholic University College of Medicine Department of Internal Medicine
ÇѼ®¿ø ( Han Sok-Won ) 
Catholic University College of Medicine Department of Internal Medicine

Abstract


Autoimmune pancreatitis (AIP) is a rare and unique type of chronic pancreatitis. The prognosis of AIP, particularly when associated with pancreatic cancer or a related malignancy, is not known. Only a few cases, where metachronous pancreas-related cancer developed during follow-up, have been reported. Most of these patients either underwent surgery or steroid therapy. This paper reports a case of a 66-year-old woman with untreated type I AIP who developed peritoneal carcinomatosis more than 2 years later. Initially, the patient had a markedly elevated serum IgG4 level and a diffuse, infiltrative mass-like lesion in the pancreatic head, in which the biopsy results were consistent with type I AIP. The patient was not treated with steroids because of a cerebellar infarction. Twenty-eight months after the diagnosis of AIP, peritoneal carcinomatosis developed without noticeable changes in the pancreas from the initial findings.

Å°¿öµå

Autoimmune pancreatitis; Immunoglobulin G4-related disease; Pancreatic neoplasms; Peritoneal neoplasms

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

  

µîÀçÀú³Î Á¤º¸

MEDLINE
KCI
KoreaMed
KAMS